Ttbio Corp.
Ttbio Corp. manufactures, sells, and maintains medical devices under the TTBIO brand name in Taiwan and the United States. The company offers high and low-speed hand piece products, dental spare parts, service rotors, maintenance units, electric hand piece systems, and precision-machined components. It serves various industries, including medical, automotive, aerospace, security, computer compone… Read more
Ttbio Corp. (6493) - Total Assets
Latest total assets as of June 2025: NT$640.77 Million TWD
Based on the latest financial reports, Ttbio Corp. (6493) holds total assets worth NT$640.77 Million TWD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Ttbio Corp. - Total Assets Trend (2019–2024)
This chart illustrates how Ttbio Corp.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Ttbio Corp. - Asset Composition Analysis
Current Asset Composition (December 2024)
Ttbio Corp.'s total assets of NT$640.77 Million consist of 61.1% current assets and 38.9% non-current assets.
| Asset Category | Amount (TWD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 13.6% |
| Accounts Receivable | NT$65.06 Million | 10.7% |
| Inventory | NT$207.22 Million | 34.1% |
| Property, Plant & Equipment | NT$0.00 | 0.0% |
| Intangible Assets | NT$43.66 Million | 7.2% |
| Goodwill | NT$0.00 | 0.0% |
Asset Composition Trend (2019–2024)
This chart illustrates how Ttbio Corp.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Ttbio Corp.'s current assets represent 61.1% of total assets in 2024, an increase from 44.9% in 2019.
- Cash Position: Cash and equivalents constituted 13.6% of total assets in 2024, down from 17.1% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 7.0% of total assets, unchanged from 7.0% in 2019.
- Asset Diversification: The largest asset category is inventory at 34.1% of total assets.
Ttbio Corp. Competitors by Total Assets
Key competitors of Ttbio Corp. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
|
China | CN¥3.82 Billion |
|
Blue Sail Medical Co Ltd
SHE:002382
|
China | CN¥16.46 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥28.98 Billion |
|
Allmed Medical Products Co Ltd Class A
SHE:002950
|
China | CN¥5.35 Billion |
|
Inix Technologies Holdings Bhd
KLSE:0094
|
Malaysia | RM72.53 Million |
|
Focus Point Holdings Bhd
KLSE:0157
|
Malaysia | RM328.19 Million |
|
Careplus Group Bhd
KLSE:0163
|
Malaysia | RM286.61 Million |
|
LKL International Bhd
KLSE:0182
|
Malaysia | RM173.46 Million |
Ttbio Corp. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Ttbio Corp. generates 0.51x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Ttbio Corp. generates $ 0.43 in net profit.
Ttbio Corp. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.61 | 1.94 | 2.33 |
| Quick Ratio | 0.73 | 0.72 | 1.14 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | NT$157.31 Million | NT$ 159.19 Million | NT$ 116.31 Million |
Ttbio Corp. - Advanced Valuation Insights
This section examines the relationship between Ttbio Corp.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.02 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 18.8% |
| Total Assets | NT$608.29 Million |
| Market Capitalization | $3.34 Million USD |
Valuation Analysis
Below Book Valuation: The market values Ttbio Corp.'s assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Ttbio Corp.'s assets grew by 18.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Ttbio Corp. (2019–2024)
The table below shows the annual total assets of Ttbio Corp. from 2019 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | NT$608.29 Million | +18.84% |
| 2023-12-31 | NT$511.86 Million | -2.82% |
| 2022-12-31 | NT$526.72 Million | +13.34% |
| 2021-12-31 | NT$464.73 Million | +13.43% |
| 2020-12-31 | NT$409.71 Million | -12.80% |
| 2019-12-31 | NT$469.87 Million | -- |